Amyris ($300M+ revenue run rate, Emeryville) produces bio-based specialty chemicals and ingredients through synthetic biology and fermentation. Partnership with Wacker announced in April 2026 targets bio-derived functional ingredient market.
Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.